Unither Manufacturing LLC in Rochester, NY, marks a decade of success and growth
2023-11-09
并购诊断试剂
Rochester, N.Y., Nov. 9, 2023 /PRNewswire/ -- Unither Manufacturing LLC celebrates this year its 10-year anniversary. Acquired in October 2013 to expand Unither Pharmaceuticals' group international presence, the Rochester (NY) site kept its previous activities while developing 2 core technologies: Blow-Fill-Seal (BFS) and Liquid Stick-pack technologies.
Continue Reading
Preview
来源: PRNewswire
Unither Manufacturing LLC in Rochester, NY
"Our goal in Rochester is to continue building capacity to support the North American needs for BFS and Liquid Stick-Pack. Why BFS? Because at UNITHER, we envision a world where preservative free ophthalmic formulation is the norm, and patients don't have to compromise between safety and efficacy. We believe that everyone deserves access to safe, effective, and affordable treatments for their eye conditions, and are committed to making that vision a reality here in the US by supporting our partners regionally. Similarly, the Stick-Pack, as a unit dose format, offers a unique and safe way to dispense oral medication. While this technology helps improving the delivery of existing medication, the Liquid Stick-Pack also shows unique benefits for the delivery of Orphan drug, allowing dosage accuracy, as well as favorizing the treatment adherence by patients." says Julien SEID, Unither's North American General Manager.
The site is involved in numerous development and technology transfer projects. For example, the CDMO is working on development projects such as PXT3003 for its customer PHARNEXT, an orphan drug for Charcot-Marie-Tooth disease type 1A (CMT1A), and but also supporting various companies specialized in Ophthalmic products in different stages, from the early stages through Phase III and commercial production of new and innovative sterile preservative-free products in BFS. The site also manufactures diagnostic reagents for Covid and Influenza tests, Cough & Cold Oral Suspension with extended release, controlled substances Oral solution and capsules.
Unither Manufacturing LLC was created by the French CDMO Unither Pharmaceuticals in October of 2013 with the acquisition of the pharmaceutical facility located at 755 Jefferson Rd. The Rochester site which is 430,500 square feet and have 320 employees is specialized in the development and manufacturing of pharmaceuticals products, generics, over-the-counter products, prescription drugs, in various dosage forms such as Sterile single dose units in Blow-Fill-Seal (BFS), Non-Sterile Liquid Stick-Packs and Non-Sterile Liquid Bottles, Controlled Substances and Extended releases capabilities. The facility is FDA approved and regularly inspected (General GMP and Sterile PAI in October of 2021, and Non-Sterile PAI in January 2020).
Contact
755 Jefferson Road
Rochester, NY 14623
Email: [email protected]
Photo - https://mma.prnewswire.com/media/1471719/Unither_Pharmaceuticals_Logo.jpg
Logo - https://mma.prnewswire.com/media/1471719/Unither_Pharmaceuticals_Logo.jpg
SOURCE Unither Pharmaceuticals
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
靶点
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。